Beijing Tong Ren Tang Chinese Medicine Company Limited announced audited consolidated earnings results for the year ended December 31, 2017. For the year, the company’s revenue was HKD 1,265,994,000 against HKD 1,084,280,000 a year ago. Operating profit was HKD 597,684,000 against HKD 527,499,000 a year ago. Profit before income tax was HKD 610,966,000 against HKD 532,270,000 a year ago. Profit attributable to owners of the company was HKD 489,967,000 against HKD 420,315,000 a year ago. Basic and diluted earnings per share attributable to owners of the company were HKD 0.59 against HKD 0.50 a year ago. The group's revenue represented an increase of 16.8% from last year. The increase was mainly driven by the continuous demand for the company’s Owned Products and the sales growth in the existing sales network and expansion of sales network. During the year, the group's capital expenditure incurred amounted to HKD 34.3 million, compared with HKD 38.8 million for the year 2016, which was primarily used for purchase of production equipment, the establishment of new retail outlets and purchase of a property for retail purpose. Net cash generated from operating activities was HKD 469,144,000 against HKD 467,721,000 a year ago.